<DOC>
	<DOCNO>NCT00004276</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate whether thalidomide modulates toxic host inflammatory response patient receive antitubercular therapy . II . Evaluate whether thalidomide modifies tumor necrosis factor-mediated toxic symptom HIV mycobacterial infection , limit progression HIV immunodeficiency . III . Evaluate whether thalidomide stimulates immunity patient HIV and/or mycobacterial infection .</brief_summary>
	<brief_title>Phase II Placebo Controlled Study Thalidomide Patients With Mycobacterial HIV Infections</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind study . Patients stratify type infection . Patients randomly assign oral thalidomide placebo . Therapy administer daily 8 week , begin night antitubercular treatment initiate .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Human immunodeficiency virus ( HIV ) mycobacterial infection require least 10 day inpatient antitubercular treatment Mycobacterial infection confirm positive acidfast bacillus smear culture Mycobacterium tuberculosis At least 1 follow sign symptom require : Temperature 38 degree C least 2 occasion within 1 week prior treatment Weight loss great 5 kg Pulmonary involvement least 1 lobe xray Night sweat least 2 occasion within 1 week prior treatment Prior/Concurrent Therapy Concurrent rifampicin , isoniazid , pyrazinamide , ethambutol tuberculosis allow Patient Characteristics No neuropathy risk neuropathy Not pregnant Negative pregnancy test Fertile patient must use effective contraception 4 week study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>bacterial infection</keyword>
	<keyword>human immunodeficiency virus infection</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>mycobacterium infection</keyword>
	<keyword>mycobacterium tuberculosis infection</keyword>
	<keyword>rare disease</keyword>
	<keyword>viral infection</keyword>
</DOC>